Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/grok-3-ai-analyzes-if-shiba-inu-shib-can-experience-a-bull-run-in-2025/